Adipose tissue as a therapeutic target for vascular damage in Alzheimer's disease

被引:10
|
作者
Bettinetti-Luque, Miriam [1 ]
Trujillo-Estrada, Laura [1 ,2 ]
Garcia-Fuentes, Eduardo [3 ,4 ]
Andreo-Lopez, Juana [1 ]
Sanchez-Varo, Raquel [1 ,2 ,5 ]
Garrido-Sanchez, Lourdes [6 ,7 ]
Gomez-Mediavilla, Angela [8 ]
Lopez, Manuela G. [8 ,9 ]
Garcia-Caballero, Melissa [10 ]
Gutierrez, Antonia [1 ,2 ]
Baglietto-Vargas, David [1 ,2 ,11 ]
机构
[1] Univ Malaga, Fac Ciencias, Dept Biol Celular Genet & Fisiol, Inst Invest Biomed Malaga IBIMA Plataforma BIONAND, Malaga, Spain
[2] Inst Salud Carlos III, CIBER Enfermedades Neurodegenerat CIBERNED, Madrid, Spain
[3] Hosp Univ Virgen De La Victoria, Unidad Gest Clin Endocrinol & Nutr, Inst Invest Biomed Malaga IBIMA Plataforma BIONAND, Malaga, Spain
[4] Inst Salud Carlos III, CIBER Enfermedades Hepat & Digest CIBEREHD, Madrid, Spain
[5] Univ Malaga, Fac Med, Dept Fisiol Humana Anat Patol & Educ Fis Deport, Malaga, Spain
[6] Inst Salud Carlos III, CIBER Fisiopatol Obes & Nutr CIBEROBN, Madrid, Spain
[7] Hosp Univ Virgen De La Victoria, Unidad Gest Clin Endocrinol & Nutr, Inst Invest Biomed Malaga IBIMA Plataforma BIONAND, Malaga, Spain
[8] Univ Autonoma Madrid, Fac Med, Dept Farmacol, Inst Teofilo Hernando ID Farmacos, Madrid, Spain
[9] Hosp Univ La Princesa, Inst Invest Sanitarias Princesa IIS IP, Madrid, Spain
[10] Univ Malaga, Fac Ciencias, Dept Biol Mol & Bioquim, Inst Invest Biomed Malaga IBIMA Plataforma BIONAND, Malaga, Spain
[11] Univ Malaga, Fac Sci, Dept Cell Biol, Genet & Physiol, Malaga 29071, Spain
关键词
adipokines; adipose tissue; Alzheimer's disease; amyloid; inflammation; tau; vascular; BLOOD-BRAIN-BARRIER; TUMOR-NECROSIS-FACTOR; INTERLEUKIN-1 RECEPTOR ANTAGONIST; TIGHT JUNCTION PROTEINS; AMYLOID PRECURSOR PROTEIN; TRANSGENIC MOUSE MODEL; BODY-MASS INDEX; NICOTINAMIDE MONONUCLEOTIDE PROTECTS; ENDOTHELIAL GROWTH-FACTOR; GLYCATION END-PRODUCTS;
D O I
10.1111/bph.16243
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Adipose tissue has recently been recognized as an important endocrine organ that plays a crucial role in energy metabolism and in the immune response in many metabolic tissues. With this regard, emerging evidence indicates that an important crosstalk exists between the adipose tissue and the brain. However, the contribution of adipose tissue to the development of age-related diseases, including Alzheimer's disease, remains poorly defined. New studies suggest that the adipose tissue modulates brain function through a range of endogenous biologically active factors known as adipokines, which can cross the blood-brain barrier to reach the target areas in the brain or to regulate the function of the blood-brain barrier. In this review, we discuss the effects of several adipokines on the physiology of the blood-brain barrier, their contribution to the development of Alzheimer's disease and their therapeutic potential.
引用
收藏
页码:840 / 878
页数:39
相关论文
共 50 条
  • [1] Myeloperoxidase as a therapeutic target for oxidative damage in Alzheimer's disease
    Antonio, Astrid Mayleth Rivera
    Martinez, Itzia Irene Padilla
    Torres-Ramos, Monica A.
    Rosales-Hernandez, Martha Cecilia
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2025, 40 (01)
  • [2] Adipose tissue macrophages as a therapeutic target in obesity-associated diseases
    Herrada, Andres A.
    Olate-Briones, Alexandra
    Rojas, Armando
    Liu, Chaohong
    Escobedo, Noelia
    Piesche, Matthias
    OBESITY REVIEWS, 2021, 22 (06)
  • [3] The Role and Therapeutic Potential of Monocytic Cells in Alzheimer's Disease
    Malm, Tarja
    Koistinaho, Milla
    Muona, Anu
    Magga, Johanna
    Koistinaho, Jari
    GLIA, 2010, 58 (08) : 889 - 900
  • [4] Association between Visceral Adipose Tissue Metabolism and Alzheimer's Disease Pathology
    Kim, Shin
    Yi, Hyon-Ah
    Won, Kyoung Sook
    Lee, Ji Soo
    Kim, Hae Won
    METABOLITES, 2022, 12 (03)
  • [5] Gelsolin as therapeutic target in Alzheimer's disease
    Carro, Eva
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2010, 14 (06) : 585 - 592
  • [6] O-GlcNAcylation as a Therapeutic Target for Alzheimer's Disease
    Park, Jinsu
    Lai, Mitchell K. P.
    Arumugam, Thiruma V.
    Jo, Dong-Gyu
    NEUROMOLECULAR MEDICINE, 2020, 22 (02) : 171 - 193
  • [7] γ-Secretase as a Therapeutic Target in Alzheimer's Disease
    Guardia-Laguarta, C.
    Pera, M.
    Lleo, A.
    CURRENT DRUG TARGETS, 2010, 11 (04) : 506 - 517
  • [8] NEUROGENESIS AS A THERAPEUTIC TARGET FOR ALZHEIMER'S DISEASE
    Fernandez-Verdecia, C. I.
    Diaz del Guante, M. A.
    Castillo-Diaz, L.
    Alvarez-Blanco, J.
    REVISTA DE NEUROLOGIA, 2009, 49 (04) : 193 - 201
  • [9] Therapeutic Strategies to Target Calcium Dysregulation in Alzheimer's Disease
    Calvo-Rodriguez, Maria
    Kharitonova, Elizabeth K.
    Bacskai, Brian J.
    CELLS, 2020, 9 (11) : 1 - 29
  • [10] Tau as a Therapeutic Target for Alzheimer's Disease
    Boutajangout, A.
    Sigurdsson, E. M.
    Krishnamurthy, P. K.
    CURRENT ALZHEIMER RESEARCH, 2011, 8 (06) : 666 - 677